SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-173906
Filing Date
2023-06-23
Accepted
2023-06-23 16:51:38
Documents
7
Effectiveness Date
2023-06-23

Document Format Files

Seq Description Document Type Size
1 S-8 d456687ds8.htm S-8 51331
2 EX-5.1 d456687dex51.htm EX-5.1 6754
3 EX-23.1 d456687dex231.htm EX-23.1 1521
4 EX-99.1 d456687dex991.htm EX-99.1 165235
5 EX-99.2 d456687dex992.htm EX-99.2 57486
6 EX-FILING FEES d456687dexfilingfees.htm EX-FILING FEES 19822
7 GRAPHIC g456687g55e34.jpg GRAPHIC 9828
  Complete submission text file 0001193125-23-173906.txt   311624
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-272895 | Film No.: 231038443
SIC: 2834 Pharmaceutical Preparations